Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
0.630
-0.014 (-2.24%)
At close: Dec 5, 2025, 4:00 PM EST
0.603
-0.027 (-4.30%)
After-hours: Dec 5, 2025, 7:56 PM EST
Virax Biolabs Group Market Cap
Virax Biolabs Group has a market cap or net worth of $4.12 million as of December 5, 2025. Its market cap has decreased by -49.53% in one year.
Market Cap
4.12M
Enterprise Value
1.22M
1-Year Change
-49.53%
Ranking
Category
Stock Price
$0.63
Market Cap Chart
Since the IPO on July 21, 2022, Virax Biolabs Group's market cap has decreased from $207.01M to $4.12M, a decrease of -98.01%. That is a compound annual growth rate of -68.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 4.21M | -56.87% |
| Dec 31, 2024 | 9.77M | 269.37% |
| Dec 29, 2023 | 2.64M | -71.76% |
| Dec 30, 2022 | 9.36M | -95.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 930.11B |
| Johnson & Johnson | 494.89B |
| AbbVie | 406.12B |
| UnitedHealth Group | 307.05B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 254.80B |
| Thermo Fisher Scientific | 220.29B |